title: [Adverse effect of the intermittent use of rifampicin in treating Hansen's disease].
authors.forename: P M
authors.initials: PM
authors.lastname: Papaiordanou
authors.forename: M L
authors.initials: ML
authors.lastname: Branchini
authors.forename: F L
authors.initials: FL
authors.lastname: Gonçales Júnior
authors.forename: F H
authors.initials: FH
authors.lastname: Aoki
authors.forename: R S
authors.initials: RS
authors.lastname: Boccato
authors.forename: M de C
authors.initials: Mde C
authors.lastname: Ramos
authors.forename: R J
authors.initials: RJ
authors.lastname: Pedro
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000368:Aged; D000743:Anemia, Hemolytic / Q000139:chemically induced; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007918:Leprosy / Q000188:drug therapy*; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced
chemical_list: D012293:Rifampin
vernacular_title: Efeito adverso do uso intermitente de rifampicina para tratamento de hanseníase.